This inventor holds 3 USPTO granted patents. Top assignee: Pentapharm Ag. Active years: 1995-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1999
Title: Douglas A Triplett: Innovator in Hematology
Introduction
Douglas A Triplett is a notable inventor based in South Muncie, Indiana. He has made significant contributions to the field of hematology, particularly through his innovative work involving snake venom. With a total of 3 patents, his research has paved the way for advancements in medical testing.
Latest Patents
One of his latest patents is focused on a phospholipid dependent prothrombin activator obtained from snake venom. This activator, purified from the venom of snakes belonging to the Elapidae family, particularly the Oxyuranus and Pseudonaja genera, has proven to be highly effective in tests for determining Lupus Anticoagulant. Based on this discovery, several clotting, chromogenic, and immunochromogenic tests have been developed to enhance diagnostic accuracy.
Another patent also centers on the test for lupus anticoagulant, reiterating the importance of the phospholipid dependent prothrombin activator. The findings from his research have led to the development of various tests that are crucial for diagnosing conditions related to blood coagulation.
Career Highlights
Douglas A Triplett is currently associated with Pentapharm AG, where he continues to innovate in the field of hematology. His work has not only contributed to scientific knowledge but has also had practical applications in medical diagnostics.
Collaborations
He collaborates with Kurt F Stocker, further enhancing the research and development efforts at Pentapharm AG. Their combined expertise is instrumental in advancing the company's objectives in medical innovation.
Conclusion
Douglas A Triplett's contributions to the field of hematology through his patents and research are commendable. His work continues to impact medical diagnostics positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
